At Shree Universal, we as a licensed drug trader and exporter improve patients and healthcare providers access to new and improved Anti Cancer Medicine by dealing in approved quality pharma products like 1mg Finasteride Tablets, 250mg Gefitinib Tablets IP, Human Normal Immunoglobulin For IP Solution, 1mg Tacrolimus Capsules, etc.
Every year, one of the major factors of concern for the healthcare sector, especially in the field of oncology, is the availability of new anticancer medicines and drugs at low cost. We as an ethical business make it easier for the global healthcare system and for those affected by this deadly disease to benefit from our trade practices as an effective medicine supplier.
We are a rising business in the pharma products trading sector and wish to excel in leaps and bounds by associating with manufacturing partners that have the best and latest drug manufacturing techniques in place, and can provide clinically tested products at competitive rates. We know that even though various chemotherapy and other drugs relevant to the field of oncology are available in the market, but most times, these formulations can have side effects if not manufactured as per prescribed drug production norms. Therefore, we do ground-breaking market research and join hands with renowned brands that can provide us with the most novel, effective, marginally priced and the safest products.
Our motto encapsulates the following:
- Fine tune our trade practices as per market needs
- Offer buyers early and subsidized access to various Anti Cancer Medicines like 1mg Finasteride Tablets, Human Normal Immunoglobulin For IP Solution, 250mg Gefitinib Tablets IP, 1mg Tacrolimus Capsules, etc.
- Deliver products in a timely manner so as to benefit the global medicine community
We believe that every life is precious and therefore people who are affected by life threatening diseases like cancer should get drugs that can improve and enhance their quality of life. We know the critical aspect of our job as an Anti Cancer Medicine trader and exporter and do our bit to generate better outcomes for patients battling this disease.
Keeping ourselves abreast of emerging concepts in the challenging field of cancer therapy, we form alliance and work in agreement with manufacturing partners and drug supply companies that are registered, hold approved licenses, adopt novel therapeutic approaches to medicine manufacture, and have necessary funds and resources to provide us effective medicines in bulk, as per need.